Saving your money for next purchases
ROZEALAMIN®（甲钴胺）
Eisai announced that the amyotrophic lateral sclerosis (ALS) treatment “ROZEALAMIN® 25 mg for injection” (methylcobalamin) has been launched in Japan. The product received manufacturing and sales approval in Japan on September 24, 2024, and was included in the Japanese National Medical Insurance Drug Price List today.
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
